Skip to content

Vericel VCEL Inventory write-downs

Inventory write-downs at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT
$761K+19.5%
Globus Medical logo
Globus MedicalGMED
$4.96M-16.8%

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's inventory write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's inventory write-downs?
Vericel (VCEL) reported inventory write-downs of $173K in Q1 2026.
What does inventory write-downs mean?
This metric captures the non-cash expense recognized when the carrying value of inventory is reduced due to obsolescence, damage, or a decline in market value below cost. It serves as an indicator of inventory management quality and potential risks related to product demand or shelf-life. High or frequent write-downs may signal inefficiencies in supply chain planning or product lifecycle management.